Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-25T00:48:51.071Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors

Published online by Cambridge University Press:  02 January 2015

Marya D. Zilberberg ,
Andrew F. Shorr ,
Scott T. Micek ,
Alex P. Hoban ,
Victor Pham ,
Joshua A. Doherty ,
Andrew M. Ramsey  and
Marin H. Kollef
Marya D. Zilberberg*
Affiliation:
School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts Evi, MedResearch Group, Goshen, Massachusetts
Andrew F. Shorr
Affiliation:
Washington Hospital Center, Washington, DC
Scott T. Micek
Affiliation:
Barnes Jewish Hospital, St. Louis, Missouri
Alex P. Hoban
Affiliation:
Barnes Jewish Hospital, St. Louis, Missouri
Victor Pham
Affiliation:
BJC Healthcare, St. Louis, Missouri
Joshua A. Doherty
Affiliation:
BJC Healthcare, St. Louis, Missouri
Andrew M. Ramsey
Affiliation:
Evi, MedResearch Group, Goshen, Massachusetts
Marin H. Kollef
Affiliation:
Barnes Jewish Hospital, St. Louis, Missouri
*
PO Box 303, Goshen, MA 01032 (Marya@evimedgroup.org)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

Healthcare-associated infections are likely to be caused by drug-resistant and possibly mixed organisms and to be treated with inappropriate antibiotics. Because prompt appropriate treatment is associated with better outcomes, we studied the epidemiology of healthcare-associated complicated skin and skin-structure infections (cSSSIs).

Patients.

Persons hospitalized with cSSSI and a positive culture result.

Methods.

We conducted a single-center retrospective cohort study from April 2006 through December 2007. We differentiated healthcare-associated from community-acquired cSSSIs by at least 1 of the following risk factors: (1) recent hospitalization, (2) recent antibiotics, (3) hemodialysis, and (4) transfer from a nursing home. Inappropriate treatment was defined as no antimicrobial therapy with activity against the offending pathogen(s) within 24 hours after collection of a culture specimen. Mixed infections were those caused by both a gram-positive and a gram-negative organism.

Results.

Among 717 hospitalized patients with cSSSI, 527 (73.5%) had healthcare-associated cSSSI. Gram-negative organisms were more common (relative risk, 1.24 [95% confidence interval, 1.14–1.35) and inappropriate treatment trended toward being more common (odds ratio, 1.29 [95% confidence interval, 0.85–1.95]) in healthcare-associated cSSSI than in community-acquired cSSSI. Mixed cSSSIs occurred in 10.6% of patients with healthcare-associated cSSSI and 6.3% of those with community-acquired cSSSI (P = .082) and were more likely to be treated inappropriately than to be nonmixed infections (odds ratio, 2.42 [95% confidence interval, 1.43–4.10]). Both median length of hospital stay (6.2 vs 2.9 days; P < .001) and mortality rate (6.6% vs 1.1%; P = .003) were significantly higher for healthcare-associated cSSSI than community-acquired cSSSI.

Conclusions.

Healthcare-associated cSSSIs are common and are likely to be caused by gram-negative organisms. Mixed infections carry a <2-fold greater risk of inappropriate treatment. Healthcare-associated cSSSIs are associated with increased mortality and prolonged length of hospital stay, compared with community-acquired cSSSIs.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 12 , December 2009 , pp. 1203 - 1210
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Klein, E, Smith, DL, Laxminarayan, R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007;13:1840–1846.Google ScholarPubMed
2.Fridkin, SK, Gaynes, RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999;20:303–316.CrossRefGoogle ScholarPubMed
3.Klevens, RM, Edwards, JR, Tenover, FC, McDonald, LC, Horan, T, Gaynes, R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006;42:389–391.CrossRefGoogle ScholarPubMed
4.Razavi, B, Apisarnthanarak, A, Mundy, LM. Clostridium difficile. Emergence of hypervirulence and fluoroquinolone resistance. Infection 2007;35:300–7.CrossRefGoogle ScholarPubMed
5.Dellit, TH, Owens, RC, McGowan, JE, et al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
6.Spellberg, B. Guidos, R, Gilbert, D, et al.The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155–164.CrossRefGoogle Scholar
7.Micek, ST, Kollef, KE, Reichley, RM, et al.Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568–73.CrossRefGoogle ScholarPubMed
8.Schramm, GE, Johnson, JA, Doherty, JA, et al.Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crir Care Med 2006;34:2069–2074.CrossRefGoogle ScholarPubMed
9.Ibrahim, EH, Sherman, G, Ward, S, et al.The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146–155.CrossRefGoogle ScholarPubMed
10.Alvarez-Lerma, F, ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996;22:387–394.Google ScholarPubMed
11.Iregui, M, Ward, S, Sherman, G, et al.Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262–268.CrossRefGoogle ScholarPubMed
12.Zilberberg, MD, Shorr, AF, Micek, MT, Mody, SH, Kollef, MH. Antimicrobial therapy escalation and hospital mortality among patients with HCAP: A single center experience. Chest 2008;134:963–8.CrossRefGoogle ScholarPubMed
13.Lipsky, BA, Weigelt, JA, Gupta, V, et al.Skin, soft tissue, bone, and joint infections in hospitalized patients: Epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 2007;28:1290–1298.CrossRefGoogle ScholarPubMed
14.National Nosocomial Infections Surveillance (NNIS) System Report. Am J Infect Control 2004;32:470.Google Scholar
15.Obritsch, MD, Fish, DN, MacLaren, R, Jung, R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004;48:4606–10.CrossRefGoogle ScholarPubMed
16.Edelsberg, J, Berger, A, Weber, DJ, Mallick, R, Kuznik, A, Oster, G. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008;29:160–169.CrossRefGoogle ScholarPubMed
17.Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.CrossRefGoogle Scholar
18.Kollef, MH, Shorr, A, Tabak, YP, et al.Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854–3862.CrossRefGoogle ScholarPubMed
19.Friedman, ND, Kaye, KS, Stout, JE, et al.Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–797.CrossRefGoogle ScholarPubMed
20.Stevens, DL, Bisno, AL, Chambers, HF, et al.Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373–1406.CrossRefGoogle ScholarPubMed
21.Carratala, J, Mykietiuk, A, Fernandez-Sabe, N, et al.Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy and clinical outcomes. Arch Intern Med 2007;167:1393–1399.CrossRefGoogle ScholarPubMed
22.Shindo, Y, Sato, S, Muruyama, E, et al.Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009;135:633–640.CrossRefGoogle Scholar
23.Morin, CA, Hadler, JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001;184:1029–34.CrossRefGoogle ScholarPubMed
24.Friedman, ND, Kaye, KS, Stout, JE, et al.Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–797.CrossRefGoogle ScholarPubMed
25.Siegman-Igra, Y, Fourer, B, Orni-Wasserlauf, R, et al.Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002;34:1431–9.CrossRefGoogle ScholarPubMed
26.McDonald, JR, Friedman, ND, Stout, JE, et al.Risk factors for ineffective therapy in patients with bloodstream infections. Arch Intern Med 2005;165:308–313.CrossRefGoogle Scholar
27.Naimi, TS, LeDell, KH, Como-Sabetti, K, et al.Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976–84.Google ScholarPubMed
28.Tambyah, PA, Habib, AG, Ng, TM, et al.Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually “healthcare associated.” Infect Control Hosp Epidemiol 2003;24:436–8.CrossRefGoogle ScholarPubMed
29.Shorr, AF, Tabak, YP, Killian, AD, et al.Healthcare-associated bloodstream infection: a distinct entity? Insights from a large US database. Crit Care Med 2006;34:2588–95.Google Scholar
30.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al.Methicillin-resistant S. aureus infection among patients in the emergency department. N Engl J Med 2006;355:666–74.CrossRefGoogle ScholarPubMed